Surgery Partners (SGRY) Liabilities and Shareholders Equity (2014 - 2026)

Surgery Partners has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $8.0 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.17% year-over-year to $8.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.1 billion (up 3.89% YoY) and the FY2025 annual result came in at $8.1 billion, up 2.91% from the prior year.
• Liabilities and Shareholders Equity retreated to $8.0 billion in Q1 2026 per SGRY's latest filing, from $8.1 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $8.1 billion in Q4 2025 and troughed at $6.3 billion in Q1 2022.
• A 5-year average of $7.2 billion and a median of $7.0 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity rose 16.07% in 2022, then increased 1.17% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $6.7 billion in 2022, then climbed by 2.91% to $6.9 billion in 2023, then rose by 14.74% to $7.9 billion in 2024, then rose by 2.91% to $8.1 billion in 2025, then dropped by 0.96% to $8.0 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $8.0 billion, $8.1 billion, and $7.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.